home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)

 
  May 20, 2021  
     
 
ComplianceOnline, Virtual Training Through WebEx
10/6/21


DAY 01(11:00 AM - 5:00 PM EDT)
  • 11.00 AM: Session Start
  • Introductions and participant expectations for the program
  • Fundamentals of Good Manufacturing Practice
    • What is GMP?
    • Purpose of GMP
    • Basis in law: US, Europe, Canada
    • Elements that apply to all virtual companies
    • Elements that depend on how operations are conducted: How to tell what applies to your company
  • Data Integrity: What it is and why it is important to GMP
  • Fundamentals of Good Clinical Practice (GCP)
    • What is GCP?
    • Purpose of GCP
    • Basis in law: US, Europe, Canada
    • Elements that apply to all virtual companies
    • Elements that depend on how operations are conducted: How to tell what applies to your company
  • Regulatory and business risks: The case for compliance
  • Virtual company organizational structure and responsibility for QA/GMP/GCP
  • Virtual company quality system structure and management
    • Policies, procedures, documentation management
    • Metrics and management review considerations
  • Selection, qualification and monitoring of contractors
    • Initial due diligence – public information sources to gage compliance
    • Qualification of vendors
    • Quality agreements – determining and documenting responsibilities for GMP
    • Vendor audit program
DAY 02(11:30 AM - 5:30 PM EDT)
  • Regulatory Inspections
    • Purpose of an inspection
    • Reasons for inspections
    • Inspections at virtual company headquarters locations – purpose and scope
    • Inspections at CMOs and Contract Labs
    • GMP inspections versus Preapproval inspections – FDA
    • GCP inspections of sponsors of clinical trials
    • EMA inspections – contrast with FDA
    • Health Canada inspections
  • Logistics for managing inspections at your location
    • Information sources about inspections on agency web sites: What you need and how to find it easily
    • Preparation for inspections
    • Overall process – ready room support
    • Receiving and hosting the inspectors
    • Providing documents
    • Answering questions
    • Interpersonal dos and don’ts for interacting with inspectors
    • Managing the exit discussion at the conclusion of the inspection
  • Inspections at your contract organizations
    • Making sure your CMO and contract lab are “PAI ready”
    • Training employees to assure inspection readiness – pitfalls to make sure you avoid
    • Conducting mock inspections effectively
  • Post-inspection communications with the inspecting agency
    • How to write an effective response
    • Common mistakes to avoid
    • Following up to ensure the response is satisfactory
    • When to request a meeting, and if granted, how best to handle it
  • Enforcement considerations
    • FDA enforcement process – domestic and ex-US
    • EMA enforcement
    • Health Canada
  • Final Q&A, discussion, and conclusion
  • 4:30 PM: Adjourn
 
 
Organized by: ComplianceOnline
Invited Speakers:

David L. Chesney, MSJ, is the Principal and General Manager for DL Chesney Consulting, LLC, providing GMP and GCP compliance consulting and training services to clients world wide. He has 47 years experience, evenly divided between the FDA and the private sector, including over 20 years as Vice President, Strategic Compliance Services for PAREXEL Consulting. Prior to joining PAREXEL Consulting, he served 23 years with the FDA as an Investigator, Supervisory Investigator, Director of Investigations and ultimately as District Director in San Francisco, managing all FDA operations in Northern California, Nevada and Hawaii.

Mr. Chesney has an MS degree in Jurisprudence, concentrating in Pharmaceutical and Medical Device Law from Seton Hall University School of Law, a Bachelor's degree in Biology from California State University, Northridge, plus three years of graduate study in Biology at CSU Northridge and CSU San Diego. Mr. Chesney is a member of the Parenteral Drug Association, where he serves on the faculty of the PDA Training and Research Institute. He is also active in the Food and Drug Law Institute and RAPS.

 
Deadline for Abstracts: 8/6/21
 
Registration:
$1,699*
(Seminar for One Registration)
June 10-11, 2021, Virtual Seminar

Register now and save $400 (Actual Price: $2,099)

E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.